peptide 1 glp 1 receptor agonist Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Agonists: A Scoping Review Peptide sequences and molecular structures

Chronic toxicity and carcinogenicity studies of the long-acting GLP-1 receptor agonist dulaglutide in rodents

Strong demand for metabolic disorder therapies is expected to continue driving market progression over the forecast period

The DPP4 Deficiency in Animal Models To date, there are several studies dealing with the question, which role DPP4 plays in vivo

To develop novel protease inhibitors with high activity and selectivity, grassypeptolide 59 was synthesized by Jason C

What you eat matters too

5 Significantly more patients taking liraglutide than placebo developed normal glucose tolerance (64% vs 16%), and body weight decreased by a mean of 5.3 kg